NEOCAL 300 флакон България - български - БАБХ (Българска агенция по безопасност на храните)

neocal 300 флакон

ДСМ ДЕНИТРАНС ООД - calcium gluconate, calcium glycerophosphate, magnesium chloride hexahydrate, caffeine - флакон - 160 mg/ml; 66 mg/ml; 64 mg/ml; 20 mg/ml - говеда, кози, коне, котки, кучета, овце, прасета

ALBIOTIC 330 mg България - български - БАБХ (Българска агенция по безопасност на храните)

albiotic 330 mg

Хювефарма ЕООД - lincomycin (като hydrochloride), neomycin (като sulfate) - интрамамарен разтвор - 330 mg/10 ml; 100 mg/10 ml - говеда

ADDIMAG 160 mg/ml + 84 mg/ml solution for infusion for cattle България - български - БАБХ (Българска агенция по безопасност на храните)

addimag 160 mg/ml + 84 mg/ml solution for infusion for cattle

alfasan nederland b.v - calcium guconate monohydrate; magnesium chloride hexahydrate - инфузионен разтвор - 160 mg/ml; 84 mg/ml - говеда

ADDIMAG 240 mg/ml + 126 mg/ml solution for infusion for cattle България - български - БАБХ (Българска агенция по безопасност на храните)

addimag 240 mg/ml + 126 mg/ml solution for infusion for cattle

alfasan nederland b.v. - calcium gluconate monohydrate; magnesium chloride hexahydrate - инфузионен разтвор - 240 mg/ml; 126 mg/ml - говеда

KALTETAN forte, 458.4  mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs /КАЛТЕТАН форте, 458,4 mg/ България - български - БАБХ (Българска агенция по безопасност на храните)

kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs /КАЛТЕТАН форте, 458,4 mg/

vet-agro multi-trade company sp. z o.o. - calcium gluconate, magnesium chloride hexahydrate, sodium glycerophosphate pentahydrate - solution for infusion - 458.4 mg/ml; 125 mg/ml; 20 mg/ml - говеда, коне, свине

KALTETAN, 250 mg/ml + 80 mg/ml + 10 mg/ml solution for infusion for horses, cattle and pigs България - български - БАБХ (Българска агенция по безопасност на храните)

kaltetan, 250 mg/ml + 80 mg/ml + 10 mg/ml solution for infusion for horses, cattle and pigs

vet-agro multi-trade company sp. z o.o - calcium gluconate, magnesium chloride hexahydrate, sodium glycerophosphate pentahydrate - solution for injection - 250 mg/ml; 80 mg/ml; 10 mg/ml - говеда, коне, свине

Zolsketil pegylated liposomal Европейски съюз - български - EMA (European Medicines Agency)

zolsketil pegylated liposomal

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Livmarli Европейски съюз - български - EMA (European Medicines Agency)

livmarli

mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.